Target intelligence / Profile preview

Host translation factor

Molecular classification
Other (group of proteins; typically not one unique molecule), Enzyme (some, such as GTPases or tRNA synthetases), Translation initiation factor, Translation elongation factor, Translation termination factor
01

Overview

Host translation factors are proteins in eukaryotic cells that facilitate the multi-step process of protein synthesis (translation) by aiding the initiation, elongation, and termination of mRNA-directed polypeptide chain formation[3][5][9]. The primary families include initiation factors (eIFs), elongation factors (eEFs), and release/termination factors (eRFs), each with multiple subtypes and roles[7]. These factors are essential for normal gene expression, cell viability, and response to environmental stimuli. Because viruses rely on host translation factors to synthesize their own proteins, various viral proteins specifically inhibit or hijack host translation factors to subvert cellular machinery and promote infection[1][2][7]. Certain translation factors are studied as potential therapeutic targets in cancer and infectious diseases, but broad-spectrum inhibition leads to major safety challenges, given the essential, non-redundant function of these proteins in all cells.

Other names
Translation factorEukaryotic translation factorProtein synthesis factor
02

Mechanism of action

Inhibition of translation initiation or elongation, usually by binding to or inactivating specific translation factors such as eIF4A or the ribosome[1][5][7]

03

Biological functions

Protein synthesisGene expressionRegulation of translation initiation, elongation, and terminationCellular response to stress and infection
04

Disease associations

Infection (viruses often target host translation factors)Cancer (dysregulation can drive oncogenesis)Neurodegenerative disease (defects in translation regulation)Other (metabolic diseases)
05

Safety considerations

Broad inhibition of host translation causes toxicity to normal cells[5]Immune and hematopoietic suppressionIncreased risk of infection due to impact on immune protein synthesis
06

Interacting drugs

Translation inhibitors (e.g., cycloheximide, puromycin, homoharringtonine, rocaglates, pateamine A) target generic translation factors or the ribosome; targeted inhibitors more often used in research than therapy[5][7]
07

Biomarkers

Levels of specific translation factors (e.g., eIF4E overexpression in some cancers)Phosphorylation states of translation factors (e.g., eIF2α phosphorylation as a marker of stress response)

Beyond the preview

Go deeper on Host translation factor.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Host translation factor.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call